Natural allergen exposure does not diminish the sensitivity of cytokine production to glucocorticosteroids in blood cells of seasonal allergic asthma and rhinitis patients

详细信息    查看全文

• 作者：SUSANNE LARSSON ; LENNART HANSSON ; LENNART GREIFF ; CLAES-GÖ ; RAN LÖ ; FDAHL ; CARL G. A. PERSSON ; PER BROBERG ; MARGARETA LINDEN
• 关键词：seasonal variation ; asthma ; allergic rhinitis ; airway inflammation ; glucocorticoids ; GM-CSF.
• 刊名：Respiratory Medicine
• 出版年：2002
• 出版时间：November 2002
• 年：2002
• 卷：96
• 期：11
• 页码：927-933
• 全文大小：150 K

文摘

Glucocorticosteroid (GCS) inhibition of cytokine production is a major anti-inflammatory mechanism. However, increased production of pro-inflammatory cytokines during allergic airway inflammation has been proposed to reduce GCS effects. This study aimed to investigate whether allergic airway inflammation due to natural allergen exposure might decrease the sensitivity of granulocyte-macrophage colony-stimulating factor (GM-CSF) production to GCS in blood cells. Blood samples were collected from patients with seasonal allergic asthma (n=10) and rhinitis (n=8) and healthy subjects (n=9), before, during, and after the birch pollen season. Whole blood cultures were stimulated with LPS (10 ng/ml) and treated with budesonide (10⁻¹¹−10⁻⁷ M) for 20 h. GM-CSF levels were analysed using immunoassay. Birch pollen exposure did not alter LPS-stimulated GM-CSF production, although disease symptoms and blood eosinophils increased in the patients. There were no significant differences in budesonide inhibition of GM-CSF production by blood cells of asthma and rhinitis patients compared with cells of healthy subjects before, during or after the birch pollen season and no change in response to allergen exposure. A concentration of 1 nM budesonide inhibited GM-CSF production by more than 50 % at all time points. In conclusion, natural allergen exposure did not reduce the sensitivity of GM-CSF production to GCS inhibition in blood cells of seasonal allergic asthma and rhinitis patients.